According to a report from the WHO, in 2022, ~830 million people worldwide had diabetes, and over 95% of diabetes cases are type 2
Slower titration schedules, dietary adjustments, and hydration minimize discomfort
Generic Timeline and Market Entry Health Canada is currently reviewing applications from multiple generic manufacturers, including established Canadian companies and international firms
Zepbound Availability Zepbound became available in Canada through standard prescription channels following Health Canada approval
Originally developed to help manage type 2 diabetes, these drugs are now widely prescribed for weight loss due to their profound appetite-suppressing effects
Clinical documentation: Your healthcare provider submits documentation that justifies that Zepbound is a medical necessity for you and meets UHCs clinical guidelines and may include documentation of your age, weight, body mass index (BMI), step therapy, and/or lifestyle modification